{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:54:07Z","timestamp":1784199247457,"version":"3.55.0"},"reference-count":207,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Predoctoral Fellowship","doi-asserted-by":"publisher","award":["17060037"],"award-info":[{"award-number":["17060037"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2014- 0474"],"award-info":[{"award-number":["PICT 2014- 0474"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2014-1121"],"award-info":[{"award-number":["PICT 2014-1121"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 0240"],"award-info":[{"award-number":["PIP 0240"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 0202"],"award-info":[{"award-number":["PIP 0202"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,5,14]]},"abstract":"<jats:sec><jats:title\/><jats:p>ATP binding cassette (ABC) transporters are transmembrane proteins expressed in secretory epithelia like the liver, kidneys and intestine, in the epithelia exhibiting barrier function such as the blood-brain barrier and placenta, and to a much lesser extent, in tissues like reproductive organs, lungs, heart and pancreas, among others. They regulate internal distribution of endogenous metabolites and xenobiotics including drugs of therapeutic use and also participate in their elimination from the body. We here describe the function and regulation of ABC transporters in the heart and small intestine, as examples of extrahepatic tissues, in which ABC proteins play clearly different roles. In the heart, they are involved in tissue pathogenesis as well as in protecting this organ against toxic compounds and druginduced oxidative stress. The small intestine is highly exposed to therapeutic drugs taken orally and, consequently, ABC transporters localized on its surface strongly influence drug absorption and pharmacokinetics. Examples of the ABC proteins currently described are Multidrug Resistance-associated Proteins 1 and 2 (MRP1 and 2) for heart and small intestine, respectively, and P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP) for both organs.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867325666180327092639","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T09:39:44Z","timestamp":1522229984000},"page":"1155-1184","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["ABC Transporters in Extrahepatic Tissues: Pharmacological Regulation in Heart and Intestine"],"prefix":"10.2174","volume":"26","author":[{"given":"Silvina","family":"Villanueva","sequence":"first","affiliation":[{"name":"Instituto de Fisiologia Experimental, Facultad de Ciencias Bioquimicas y Farmaceuticas, CONICET-UNR. 2000 Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Toxicology & Cancer Biology, University of Kentucky, Lexington, KY 40536-0305, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Zecchinati","sequence":"additional","affiliation":[{"name":"Instituto de Fisiologia Experimental, Facultad de Ciencias Bioquimicas y Farmaceuticas, CONICET-UNR. 2000 Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Mottino","sequence":"additional","affiliation":[{"name":"Instituto de Fisiologia Experimental, Facultad de Ciencias Bioquimicas y Farmaceuticas, CONICET-UNR. 2000 Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Vore","sequence":"additional","affiliation":[{"name":"Department of Toxicology & Cancer Biology, University of Kentucky, Lexington, KY 40536-0305, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","volume":"38","author":"Zhou S.F.","year":"2008","unstructured":"Zhou SF. Xenobiotica, Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.,, 2008, 38,, 802-832,","journal-title":"Xenobiotica"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00272381","volume":"77","author":"Callen D.F.","year":"1987","unstructured":"Callen DF, Baker E, Simmers RN, Seshadri R, Roninson IB. Hum Genet, Localization of the human multiple drug resistance gene, MDR1, to 7q21.1.,, 1987, 77,, 142-144,","journal-title":"Hum Genet"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"12053","DOI":"10.1016\/S0021-9258(18)80173-9","volume":"264","author":"Hsu S.I.","year":"1989","unstructured":"Hsu SI, Lothstein L, Horwitz SB. J Biol Chem, Differential overexpression of three mdr gene family members in multidrugresistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes.,, 1989, 264,, 12053-12062,","journal-title":"J Biol Chem"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/mp900253n","volume":"6","author":"Benet L.Z.","year":"2009","unstructured":"Benet LZ. Mol Pharm, The drug transporter-metabolism alliance: uncovering and defining the interplay.,, 2009, 6,, 1631-1643,","journal-title":"Mol Pharm"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","volume":"92","author":"Borst P.","year":"2000","unstructured":"Borst P, Evers R, Kool M, Wijnholds J. J Natl Cancer Inst, A family of drug transporters: the multidrug resistance-associated proteins.,, 2000, 92,, 1295-1302,","journal-title":"J Natl Cancer Inst"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","volume":"258","author":"Cole S.P.","year":"1992","unstructured":"Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. Science, Overexpression of a transporter gene in a multidrugresistant human lung cancer cell line.,, 1992, 258,, 1650-1654,","journal-title":"Science"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"27807","DOI":"10.1016\/S0021-9258(18)46856-1","volume":"269","author":"Leier I.","year":"1994","unstructured":"Leier I, Jedlitschky G, Buchholz U, Cole SP, Deeley RG, Keppler D. J Biol Chem, The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates.,, 1994, 269,, 27807-27810,","journal-title":"J Biol Chem"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-J","volume":"20","author":"Cole S.P.","year":"1998","unstructured":"Cole SP, Deeley RG. BioEssays, Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP.,, 1998, 20,, 931-940,","journal-title":"BioEssays"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/bj3500555","volume":"350","author":"Renes J.","year":"2000","unstructured":"Renes J, de Vries EE, Hooiveld GJ, Krikken I, Jansen PL, M\u00fcller M. Biochem J, Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal.,, 2000, 350,, 555-561,","journal-title":"Biochem J"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"27846","DOI":"10.1074\/jbc.M102453200","volume":"276","author":"Leslie E.M.","year":"2000","unstructured":"Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, Cole SP. J Biol Chem, Transport of the \u03b2-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog.,, 2000, 276,, 27846-27854,","journal-title":"J Biol Chem"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/FPC.0b013e328350e270","volume":"22","author":"Jungsuwadee P.","year":"2012","unstructured":"Jungsuwadee P, Zhao T, Stolarczyk EI, Paumi CM, Butterfield DA, St Clair DK, Vore M. Pharmacogenet Genomics, The G671V variant of MRP1\/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenal.,, 2012, 22,, 273-284,","journal-title":"Pharmacogenet Genomics"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","volume":"95","author":"Doyle L.A.","year":"1998","unstructured":"Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD. Proc Natl Acad Sci USA, A multidrug resistance transporter from human MCF-7 breast cancer cells.,, 1998, 95,, 15665-15670,","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","volume":"22","author":"Doyle L.A.","year":"2003","unstructured":"Doyle LA, Ross DD. Oncogene, Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).,, 2003, 22,, 7340-7358,","journal-title":"Oncogene"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00204-014-1224-8","volume":"88","author":"Jani M.","year":"2014","unstructured":"Jani M, Ambrus C, Magnan R, Jakab KT, Be\u00e9ry E, Zolnerciks JK, Krajcsi P. Arch Toxicol, Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.,, 2014, 88,, 1205-1248,","journal-title":"Arch Toxicol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","volume":"55","author":"Schinkel A.H.","year":"2003","unstructured":"Schinkel AH, Jonker JW. Adv Drug Deliv Rev, Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.,, 2003, 55,, 3-29,","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","volume":"84","author":"Thiebaut F.","year":"1987","unstructured":"Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Proc Natl Acad Sci USA, Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.,, 1987, 84,, 7735-7738,","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.V881213","volume":"8","author":"Schaub T.P.","year":"1997","unstructured":"Schaub TP, Kartenbeck J, K\u00f6nig J, Vogel O, Witzgall R, Kriz W, Keppler D. J Am Soc Nephrol, Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules.,, 1997, 8,, 1213-1221,","journal-title":"J Am Soc Nephrol"},{"key":"ref=18","first-page":"6172","volume":"62","author":"Belinsky M.G.","year":"2002","unstructured":"Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD. Cancer Res, Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).,, 2002, 62,, 6172-6177,","journal-title":"Cancer Res"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4161\/cc.7.11.6005","volume":"7","author":"Borst P.","year":"2008","unstructured":"Borst P, van de Wetering K, Schlingemann R. Cell Cycle, Does the absence of ABCC6 (multidrug resistance protein 6) in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery?,, 2008, 7,, 1575-1579,","journal-title":"Cell Cycle"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.ki.5002645","volume":"73","author":"Huls M.","year":"2008","unstructured":"Huls M, Brown CD, Windass AS, Sayer R, van den Heuvel JJ, Heemskerk S, Russel FG, Masereeuw R. Kidney Int, The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane.,, 2008, 73,, 220-225,","journal-title":"Kidney Int"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","volume":"106","author":"Woodward O.M.","year":"2009","unstructured":"Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, K\u00f6ttgen M. Proc Natl Acad Sci USA, Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.,, 2009, 106,, 10338-10342,","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/17425255.2012.667401","volume":"8","author":"Lepist E.I.","year":"2012","unstructured":"Lepist EI, Ray AS. Expert Opin Drug Metab Toxicol, Renal drug-drug interactions: what we have learned and where we are going.,, 2012, 8,, 433-448,","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1517\/17425255.1.2.233","volume":"1","author":"Scherrmann J.M.","year":"2005","unstructured":"Scherrmann JM. Expert Opin Drug Metab Toxicol, Expression and function of multidrug resistance transporters at the blood-brain barriers.,, 2005, 1,, 233-246,","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1369\/jhc.5A6870.2006","volume":"54","author":"Bendayan R.","year":"2006","unstructured":"Bendayan R, Ronaldson PT, Gingras D, Bendayan M. J Histochem Cytochem, In situ localization of P-glycoprotein (ABCB1) in human and rat brain.,, 2006, 54,, 1159-1167,","journal-title":"J Histochem Cytochem"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/00001756-200211150-00014","volume":"13","author":"Cooray H.C.","year":"2002","unstructured":"Cooray HC, Blackmore CG, Maskell L, Barrand MA. Neuroreport, Localisation of breast cancer resistance protein in microvessel endothelium of human brain.,, 2002, 13,, 2059-2063,","journal-title":"Neuroreport"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1007\/s11095-007-9244-1","volume":"24","author":"Lee G.","year":"2007","unstructured":"Lee G, Babakhanian K, Ramaswamy M, Prat A, Wosik K, Bendayan R. Pharm Res, Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems.,, 2007, 24,, 1262-1274,","journal-title":"Pharm Res"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","volume":"1628","author":"Qosa H.","year":"2005","unstructured":"Qosa H, Miller DS. Brain Res, Pasinelli, P3.; Trotti, D. Regulation of ABCefflux transporters at blood-brain barrier in health and neurological disorders.,, 2005, 1628,, 298-316,","journal-title":"Brain Res"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cne.21808","volume":"510","author":"Gazzin S.","year":"2008","unstructured":"Gazzin S, Strazielle N, Schmitt C, Fevre-Montange M, Ostrow JD, Tiribelli C, Ghersi-Egea JF. J Comp Neurol, Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces.,, 2008, 510,, 497-507,","journal-title":"J Comp Neurol"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0028-1103272","volume":"39","author":"Daood M.","year":"2008","unstructured":"Daood M, Tsai C, Ahdab-Barmada M, Watchko JF. Neuropediatrics, ABC transporter (P-gp\/ABCB1,MRP1\/ABCC1, BCRP\/ABCG2) expression in the developing human CNS.,, 2008, 39,, 211-218,","journal-title":"Neuropediatrics"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/pr.58.2.3","volume":"58","author":"Dallas S.","year":"2006","unstructured":"Dallas S, Miller DS, Bendayan R. Pharmacol Rev, Multidrug resistance- associated proteins: expression and function in the central nervous system.,, 2006, 58,, 140-161,","journal-title":"Pharmacol Rev"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.103.054304","volume":"307","author":"Dallas S.","year":"2003","unstructured":"Dallas S, Zhu X, Baruchel S, Schlichter L, Bendayan R. J Pharmacol Exp Ther, Functional expression of the multidrug resistance protein 1 in microglia.,, 2003, 307,, 282-290,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"C849","DOI":"10.1152\/ajpcell.00283.2008","volume":"295","author":"Jones D.P.","year":"2008","unstructured":"Jones DP. Am J Physiol Cell Physiol, Radical-free biology of oxidative stress.,, 2008, 295,, C849-C868,","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pharmtox-011613-135959","volume":"54","author":"Cole S.P.","year":"2014","unstructured":"Cole SP. Annu Rev Pharmacol Toxicol, Targeting the multidrug resistance protein (MRP1, ABCC1): past, present and future.,, 2014, 54,, 95-117,","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=34","first-page":"5238","volume":"57","author":"Lorico A.","year":"1997","unstructured":"Lorico A, Rappa G, Finch RA, Yang D, Flavell RA, Sartorelli AC. Cancer Res, Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione.,, 1997, 57,, 5238-5242,","journal-title":"Cancer Res"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1124\/jpet.115.225490","volume":"355","author":"Deng J.","year":"2015","unstructured":"Deng J, Coy D, Zhang W, Sunkara M, Morris AJ, Wang C, Chaiswing L, St Clair D, Vore M, Jungsuwadee P. J Pharmacol Exp Ther, Elevated glutathione in multidrug resistance associated protein 1 (Mrp1\/Abcc1) null mice does not protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1\/Abcc1) null mice.,, 2015, 355,, 272-279,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/jpet.115.225581","volume":"355","author":"Zhang W.","year":"2015","unstructured":"Zhang W, Deng J, Sunkara M, Morris AJ, Wang C, St Clair D, Vore M. J Pharmacol Exp Ther, Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.,, 2015, 355,, 280-287,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1471-4159.2001.00101.x","volume":"76","author":"Hirrlinger J.","year":"2001","unstructured":"Hirrlinger J, K\u00f6nig J, Keppler D, Lindenau J, Schulz JB, Dringen R. J Neurochem, The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress.,, 2001, 76,, 627-636,","journal-title":"J Neurochem"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1471-4159.2006.03737.x","volume":"97","author":"Minich T.","year":"2006","unstructured":"Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, Dringen R. J Neurochem, The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes.,, 2006, 97,, 373-384,","journal-title":"J Neurochem"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tips.2006.06.008","volume":"27","author":"Cole S.P.","year":"2006","unstructured":"Cole SP, Deeley RG. Trends Pharmacol Sci, Transport of glutathione and glutathione conjugates by MRP1.,, 2006, 27,, 438-446,","journal-title":"Trends Pharmacol Sci"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/toxsci\/kfw021","volume":"151","author":"Zhang W.","year":"2016","unstructured":"Zhang W, St Clair D, Butterfield DA, Vore M. Toxicol Sci, Loss of Mrp1 potentiates Doxorubicin-induced cardiotoxicity in neonatal mouse cardiomyocytes and cardiac fibroblasts.,, 2016, 151,, 44-56,","journal-title":"Toxicol Sci"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1073\/pnas.120159197","volume":"97","author":"Wijnholds J.","year":"2000","unstructured":"Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, Balzarini J, Borst P. Proc Natl Acad Sci USA, Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs.,, 2000, 97,, 7476-7481,","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1124\/jpet.104.065201","volume":"310","author":"Sasabe H.","year":"2004","unstructured":"Sasabe H, Kato Y, Suzuki T, Hose M, Miyamoto G, Sugiyama Y. J Pharmacol Exp Ther, Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice.,, 2004, 310,, 648-655,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3727\/0965040041292387","volume":"14","author":"Muramatsu T.","year":"2004","unstructured":"Muramatsu T, Johnson DR, Finch RA, Johnson LK, Leffert JJ, Lin ZP, Pizzorno G, Sartorelli AC. Oncol Res, Age-related differences in vincristine toxicity and biodistribution in wild-type and transporter-deficient mice.,, 2004, 14,, 331-343,","journal-title":"Oncol Res"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1124\/mol.52.3.344","volume":"52","author":"Stride B.D.","year":"1997","unstructured":"Stride BD, Grant CE, Loe DW, Hipfner DR, Cole SP, Deeley RG. Mol Pharmacol, Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.,, 1997, 52,, 344-353,","journal-title":"Mol Pharmacol"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.freeradbiomed.2005.02.015","volume":"38","author":"Volkel W.","year":"2005","unstructured":"Volkel W, Alvarez-Sanchez R, Weick I, Mally A, Dekant W, Pahler A. Free Radic Biol Med, Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats.,, 2005, 38,, 1526-1536,","journal-title":"Free Radic Biol Med"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","volume":"112","author":"Wojnowski L.","year":"2005","unstructured":"Wojnowski L, Kulle B, Schirmer M, Schl\u00fcter G, Schmidt A, Rosenberger A. Circulation, NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity.,, 2005, 112,, 3754-3762,","journal-title":"Circulation"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1535-7163.MCT-06-0297","volume":"5","author":"Jungsuwadee P.","year":"2006","unstructured":"Jungsuwadee P, Cole MP, Sultana R, Joshi G, Tangpong J, Butterfield DA, St. Clair DK, Vore M. Mol Cancer Ther, Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL\/6 mice.,, 2006, 5,, 2851-2860,","journal-title":"Mol Cancer Ther"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/CBI20110264","volume":"36","author":"Semsei A.F.","year":"2012","unstructured":"Semsei AF, Erdelyi DJ, Ungvari I, Csagoly E, Hegyi MZ, Kiszel PS. Cell Biol Int, ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia.,, 2012, 36,, 79-86,","journal-title":"Cell Biol Int"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2010.34.3467","volume":"30","author":"Visscher H.","year":"2012","unstructured":"Visscher H, Ross CJ, Rassekh SR, Barhdadi A, Dub\u00e9 MP, Al-Saloos H. J Clin Oncol, Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.,, 2012, 30,, 1422-1428,","journal-title":"J Clin Oncol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbrc.2003.09.086","volume":"310","author":"Hayashi A.","year":"2003","unstructured":"Hayashi A, Suzuki H, Itoh K, Yamamoto M, Sugiyama Y. Biochem Biophys Res Commun, Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein1 in mouse embryo fibroblasts.,, 2003, 310,, 824-829,","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2443.2003.00640.x","volume":"8","author":"Itoh K.","year":"2003","unstructured":"Itoh K, Wakabayashi N, Katoh Y, Ishii T, O\u2019Connor T, Yamamoto M. Genes Cells, Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles.,, 2003, 8,, 379-391,","journal-title":"Genes Cells"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"32485","DOI":"10.1074\/jbc.M503074200","volume":"280","author":"Nguyen T.","year":"2005","unstructured":"Nguyen T, Sherratt PJ, Nioi P, Yang CS, Pickett CB. J Biol Chem, Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1.,, 2005, 280,, 32485-32492,","journal-title":"J Biol Chem"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/002215540205001008","volume":"50","author":"Meissner K.","year":"2002","unstructured":"Meissner K, Sperker B, Karsten C, Meyer Z, Schwabedissen H, Seeland U, B\u00f6hm M, Bien S, Dazert P, Kunert-Keil C, Vogelgesang S, Warzok R, Siegmund W, Cascorbi I, Wendt M, Kroemer HK. J Histochem Cytochem, Expression and localization of Pglycoprotein in human heart: effects of cardiomyopathy.,, 2002, 50,, 1351-1356,","journal-title":"J Histochem Cytochem"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1369\/jhc.4A6542.2005","volume":"53","author":"Lazarowski A.J.","year":"2005","unstructured":"Lazarowski AJ, Garc\u00eda Rivello HJ, Vera Janavel GL, Cuniberti LA, Cabeza Meckert PM, Yannarelli GG, Mele A, Crottogini AJ, Laguens RP. J Histochem Cytochem, Cardiomyocytes of chronically ischemic pig hearts express the MDR-1 gene-encoded P-glycoprotein.,, 2005, 53,, 845-850,","journal-title":"J Histochem Cytochem"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"Schinkel A.H.","year":"1994","unstructured":"Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, Berns AJM, Borst P. Cell, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.,, 1994, 77,, 491-502,","journal-title":"Cell"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","volume":"97","author":"Schinkel A.H.","year":"1996","unstructured":"Schinkel AH, Wagenaar E, Mol CA, van Deemter L. J Clin Invest, P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.,, 1996, 97,, 2517-2524,","journal-title":"J Clin Invest"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1124\/jpet.102.035436","volume":"302","author":"Cox D.S.","year":"2002","unstructured":"Cox DS, Scott KR, Gao H, Eddington ND. J Pharmacol Exp Ther, Effect of P-glycoprotein on the pharmacokinetics and tissue distribution of enaminone anticonvulsants: analysis by population and physiological approaches.,, 2002, 302,, 1096-1104,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.bjc.6690019","volume":"79","author":"Van Asperen J.","year":"1999","unstructured":"Van Asperen J, van Tellingen O, Tijssen F, Schinkel AH, Beijnen JH. Br J Cancer, Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein.,, 1999, 79,, 108-113,","journal-title":"Br J Cancer"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/10430349950017950","volume":"10","author":"Dell\u2019Acqua G.","year":"1999","unstructured":"Dell\u2019Acqua G, Polishchuck R, Fallon JT, Gordon JW. Hum Gene Ther, Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain\/human multiple drug resistance 1 fusion gene.,, 1999, 10,, 1269-1279,","journal-title":"Hum Gene Ther"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0887-2333(99)00087-9","volume":"14","author":"Estevez M.D.","year":"2000","unstructured":"Estevez MD, Wolf A, Schramm U. Toxicol In Vitro, Effect of PSC 833, verapamil and amiodarone on adriamycin toxicity in cultured rat cardiomyocytes.,, 2000, 14,, 17-23,","journal-title":"Toxicol In Vitro"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/jnci\/84.21.1653","volume":"84","author":"Sridhar R.","year":"1992","unstructured":"Sridhar R, Dwivedi C, Anderson J, Baker PB, Sharma HM, Desai P, Engineer FN. J Natl Cancer Inst, Effects of verapamil on the acute toxicity of doxorubicin in vivo.,, 1992, 84,, 1653-1660,","journal-title":"J Natl Cancer Inst"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.200011","volume":"20","author":"Bunting K.D.","year":"2002","unstructured":"Bunting KD. Stem Cells, ABC transporters as phenotypic markers and functional regulators of stem cells.,, 2002, 20,, 11-20,","journal-title":"Stem Cells"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1083\/jcb.200603014","volume":"176","author":"Oyama T.","year":"2007","unstructured":"Oyama T, Nagai T, Wada H, Naito AT, Matsuura K, Iwanaga K, Takahashi T, Goto M, Mikami Y, Yasuda N, Akazawa H, Uezumi A, Takeda S, Komuro I. J Cell Biol, Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo.,, 2007, 176,, 329-341,","journal-title":"J Cell Biol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/scd.2015.0272","volume":"25","author":"Doyle M.J.","year":"2016","unstructured":"Doyle MJ, Maher TJ, Li Q, Garry MG, Sorrentino BP, Martin CM. Stem Cells Dev, Abcg2-Labeled Cells Contribute to Different Cell Populations in the Embryonic and Adult Heart.,, 2016, 25,, 277-284,","journal-title":"Stem Cells Dev"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/ATVBAHA.110.211755","volume":"30","author":"Higashikuni Y.","year":"2010","unstructured":"Higashikuni Y, Sainz J, Nakamura K, Takaoka M, Enomoto S, Iwata H, Sahara M, Tanaka K, Koibuchi N, Ito S, Kusuhara H, Sugiyama Y, Hirata Y, Nagai R, Sata M. Arterioscler Thromb Vasc Biol, The ATP-binding cassette transporter BCRP1\/ABCG2 plays a pivotal role in cardiac repair after myocardial infarction via modulation of microvascular endothelial cell survival and function.,, 2010, 30,, 2128-2135,","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/ATVBAHA.111.240341","volume":"32","author":"Higashikuni Y.","year":"2012","unstructured":"Higashikuni Y, Sainz J, Nakamura K, Takaoka M, Enomoto S, Iwata H, Tanaka K, Sahara M, Hirata Y, Nagai R, Sata M. Arterioscler Thromb Vasc Biol, The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.,, 2012, 32,, 654-661,","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCRESAHA.107.161729","volume":"102","author":"Martin C.M.","year":"2008","unstructured":"Martin CM, Ferdous A, Gallardo T, Humphries C, Sadek H, Caprioli A, Garcia JA, Szweda LI, Garry MG, Garry DJ. Circ Res, Hypoxia-inducible factor-2\u03b1 transactivates Abcg2 and promotes cytoprotection in cardiac side population cells.,, 2008, 102,, 1075-1081,","journal-title":"Circ Res"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"H1610","DOI":"10.1152\/ajpheart.00638.2013","volume":"306","author":"Maher T.J.","year":"2014","unstructured":"Maher TJ, Ren Y, Li Q, Braunlin E, Garry MG, Sorrentino BP, Martin CM. Am J Physiol Heart Circ Physiol, ATP-binding cassette transporter Abcg2 lineage contributes to the cardiac vasculature after oxidative stress.,, 2014, 306,, H1610-H1618,","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1124\/dmd.115.066654","volume":"44","author":"Takeuchi R.","year":"2016","unstructured":"Takeuchi R, Shinozaki K, Nakanishi T, Tamai I. Drug Metab Dispos, Local Drug-Drug Interaction of Donepezil with Cilostazol at Breast Cancer Resistance Protein (ABCG2) Increases Drug Accumulation in Heart.,, 2016, 44,, 68-74,","journal-title":"Drug Metab Dispos"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jjcc.2009.03.011","volume":"54","author":"Takaya T.","year":"2009","unstructured":"Takaya T, Okamoto M, Yodoi K, Hata K, Kijima Y, Nakajima H, Nishikawa Y, Kita T, Ito M, Seo T, Kawashima S. J Cardiol, Torsades de Pointes with QT prolongation related to donepezil use.,, 2009, 54,, 507-511,","journal-title":"J Cardiol"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2169\/internalmedicine.48.2181","volume":"48","author":"Tanaka A.","year":"2009","unstructured":"Tanaka A, Koga S, Hiramatsu Y. Intern Med, Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de Pointes.,, 2009, 48,, 1219-1223,","journal-title":"Intern Med"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1248\/yakushi.132.237","volume":"132","author":"Shinozaki K.","year":"2012","unstructured":"Shinozaki K. Yakugaku Zasshi, Shortening of donepezil-induced QTc prolongation with a change in the interacting drug, after electrocardiograph monitoring by community pharmacists: a case report.,, 2012, 132,, 237-241,","journal-title":"Yakugaku Zasshi"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.genhosppsych.2013.04.007","volume":"35","author":"Igeta H.","year":"2013","unstructured":"Igeta H. Gen Hosp Psychiatry, Suzuki., Y; Motegi., T; Sasaki., A; Yokoyama., Y; Someya., T. Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer\u2019s disease.,, 2013, 35,, 680-,","journal-title":"Gen Hosp Psychiatry"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0014-2999(03)01552-8","volume":"466","author":"Mitani A.","year":"2003","unstructured":"Mitani A, Nakahara T, Sakamoto K, Ishii K. Eur J Pharmacol, Expression of multidrug resistance protein 4 and 5 in the porcine coronary and pulmonary arteries.,, 2003, 466,, 223-224,","journal-title":"Eur J Pharmacol"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0002-9440(10)63513-4","volume":"163","author":"Dazert P.","year":"2003","unstructured":"Dazert P, Meissner K, Vogelgesang S, Heydrich B, Eckel L, B\u00f6hm M, Warzok R, Kerb R, Brinkmann U, Schaeffeler E, Schwab M, Cascorbi I, Jedlitschky G, Kroemer HK. Am J Pathol, Expression and localization of the multidrug resistance protein 5 (MRP5\/ ABCC5), a cellular export pump for cyclic nucleotides, in human heart.,, 2003, 163,, 1567-1577,","journal-title":"Am J Pathol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","volume":"84","author":"Fojo A.T.","year":"1987","unstructured":"Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Proc Natl Acad Sci USA, Expression of a multidrug-resistance gene in human tumors and tissues.,, 1987, 84,, 265-269,","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)29314-9","volume":"299","author":"Taipalensuu J.","year":"2001","unstructured":"Taipalensuu J, T\u00f6rnblom H, Lindberg G, Einarsson C, Sj\u00f6qvist F, Melhus H, Garberg P, Sj\u00f6str\u00f6m B, Lundgren B, Artursson P. J Pharmacol Exp Ther, ,, 2001, 299,, 164-170,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/mol.104.009019","volume":"67","author":"Burk O.","year":"2005","unstructured":"Burk O, Arnold KA, Nussler AK, Schaeffeler E, Efimova E, Avery BA, Avery MA, Fromm MF, Eichelbaum M. Mol Pharmacol, Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor.,, 2005, 67,, 1954-1965,","journal-title":"Mol Pharmacol"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/13880209.2016.1241810","volume":"55","author":"Ma L.","year":"2017","unstructured":"Ma L, Wei S, Yang B, Ma W, Wu X, Ji H, Sui H, Chen J. Pharm Biol, Chrysosplenetin inhibits artemisinin efflux in P-gp-over-expressing Caco-2 cells and reverses P-gp\/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine.,, 2017, 55,, 374-380,","journal-title":"Pharm Biol"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/AAC.02531-12","volume":"57","author":"Perdomo V.G.","year":"2013","unstructured":"Perdomo VG, Rigalli JP, Villanueva SS, Ruiz ML, Luquita MG, Echenique CG, Catania VA. Antimicrob Agents Chemother, Modulation of biotransformation systems and ABC transporters by benznidazole in rats.,, 2013, 57,, 4894-4902,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"e1951","DOI":"10.1371\/journal.pntd.0001951","volume":"6","author":"Rigalli J.P.","year":"2012","unstructured":"Rigalli JP, Perdomo VG, Luquita MG, Villanueva SS, Arias A, Theile D, Weiss J, Mottino AD, Ruiz ML, Catania VA. PLoS Negl Trop Dis, Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane X-receptor.,, 2012, 6,, e1951-,","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0026-895X(25)08713-9","volume":"49","author":"Schuetz E.G.","year":"1996","unstructured":"Schuetz EG, Beck WT, Schuetz JD. Mol Pharmacol, Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.,, 1996, 49,, 311-318,","journal-title":"Mol Pharmacol"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","volume":"104","author":"Greiner B.","year":"1999","unstructured":"Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, Kroemer HK. J Clin Invest, The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.,, 1999, 104,, 147-153,","journal-title":"J Clin Invest"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1067\/mcp.2000.109797","volume":"68","author":"Westphal K.","year":"2000","unstructured":"Westphal K, Weinbrenner A, Zschiesche M, Franke G, Knoke M, Oertel R, Fritz P, von Richter O, Warzok R, Hachenberg T, Kauffmann HM, Schrenk D, Terhaag B, Kroemer HK, Siegmund W. Clin Pharmacol Ther, Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug\/drug interaction.,, 2000, 68,, 345-355,","journal-title":"Clin Pharmacol Ther"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1074\/jbc.M010173200","volume":"276","author":"Geick A.","year":"2001","unstructured":"Geick A, Eichelbaum M, Burk O. J Biol Chem, Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin.,, 2001, 276,, 14581-14587,","journal-title":"J Biol Chem"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/bjp.2008.69","volume":"154","author":"Haslam I.S.","year":"2008","unstructured":"Haslam IS, Jones K, Coleman T, Simmons NL. Br J Pharmacol, Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells.,, 2008, 154,, 246-255,","journal-title":"Br J Pharmacol"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2133\/dmpk.DMPK-10-RG-075","volume":"26","author":"Naruhashi K.","year":"2011","unstructured":"Naruhashi K, Kurahashi Y, Fujita Y, Kawakita E, Yamasaki Y, Hattori K, Nishimura A, Shibata N. Drug Metab Pharmacokinet, Comparison of the expression and function of ATP binding cassette transporters in Caco-2 and T84 cells on stimulation by selected endogenous compounds and xenobiotics.,, 2011, 26,, 145-153,","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/MCB.18.7.4377","volume":"18","author":"Jin S.","year":"1998","unstructured":"Jin S, Scotto KW. Mol Cell Biol, Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y.,, 1998, 18,, 4377-4384,","journal-title":"Mol Cell Biol"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/dmdi-2013-0056","volume":"29","author":"Kwatra D.","year":"2014","unstructured":"Kwatra D, Vadlapudi AD, Vadlapatla RK, Khurana V, Pal D, Mitra AK. Drug Metabol Drug Interact, Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters.,, 2014, 29,, 101-110,","journal-title":"Drug Metabol Drug Interact"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bcp.2008.07.020","volume":"76","author":"Haslam I.S.","year":"2008","unstructured":"Haslam IS, Jones K, Coleman T, Simmons NL. Biochem Pharmacol, Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84).,, 2008, 76,, 850-861,","journal-title":"Biochem Pharmacol"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1254\/jphs.08209FP","volume":"109","author":"Weiss J.","year":"2009","unstructured":"Weiss J, Herzog M, K\u00f6nig S, Storch CH, Ketabi-Kiyanvash N, Haefeli WE. J Pharmacol Sci, Induction of multiple drug transporters by efavirenz.,, 2009, 109,, 242-250,","journal-title":"J Pharmacol Sci"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00002030-200006160-00034","volume":"14","author":"Perloff M.D.","year":"2000","unstructured":"Perloff MD, von Moltke LL, Fahey JM, Daily JP, Greenblatt DJ. AIDS, Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture.,, 2000, 14,, 1287-1289,","journal-title":"AIDS"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijantimicag.2013.01.004","volume":"41","author":"Weiss J.","year":"2013","unstructured":"Weiss J, Haefeli WE. Int J Antimicrob Agents, Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro.,, 2013, 41,, 484-487,","journal-title":"Int J Antimicrob Agents"},{"key":"ref=94","first-page":"361","volume":"1","author":"Chin K.V.","year":"1990","unstructured":"Chin KV, Chauhan SS, Pastan I, Gottesman MM. Cell Growth Differ, Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells.,, 1990, 1,, 361-365,","journal-title":"Cell Growth Differ"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-009-1221-4","volume":"66","author":"Harmsen S.","year":"2010","unstructured":"Harmsen S, Meijerman I, Febus CL, Maas-Bakker RF, Beijnen JH, Schellens JH. Cancer Chemother Pharmacol, PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line.,, 2010, 66,, 765-771,","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00204-010-0587-8","volume":"85","author":"Silva R.","year":"2011","unstructured":"Silva R, Carmo H, Dinis-Oliveira R, Cordeiro-da-Silva A, Lima SC, Carvalho F, Bastos ML, Remi\u00e3o F. Arch Toxicol, In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells.,, 2011, 85,, 315-326,","journal-title":"Arch Toxicol"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.fitote.2013.05.019","volume":"89","author":"Wongwanakul R.","year":"2013","unstructured":"Wongwanakul R, Vardhanabhuti N, Siripong P. Fitoterapia, ianmongkol, S. Effects of rhinacanthin-C on function and expression of drug efflux transporters in Caco-2 cells.,, 2013, 89,, 80-85,","journal-title":"Fitoterapia"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/ijms14010158","volume":"14","author":"Lo Y.L.","year":"2012","unstructured":"Lo YL. Int J Mol Sci, A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells.,, 2012, 14,, 158-176,","journal-title":"Int J Mol Sci"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ejps.2012.12.019","volume":"48","author":"Harmsen S.","year":"2013","unstructured":"Harmsen S, Meijerman I, Maas-Bakker RF, Beijnen JH, Schellens JH. Eur J Pharm Sci, PXR-mediated P-glycoprotein induction by small molecule tyrosine kinase inhibitors.,, 2013, 48,, 644-649,","journal-title":"Eur J Pharm Sci"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12020-014-0517-2","volume":"49","author":"Theile D.","year":"2015","unstructured":"Theile D, Haefeli WE, Weiss J. Endocrine, Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.,, 2015, 49,, 842-853,","journal-title":"Endocrine"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0006-2952(96)00512-6","volume":"52","author":"Schrenk D.","year":"1996","unstructured":"Schrenk D, Michalke A, Gant TW, Brown PC, Silverman JA, Thorgeirsson SS. Biochem Pharmacol, Multidrug resistance gene expression in rodents and rodent hepatocytes treated with mitoxantrone.,, 1996, 52,, 1453-1460,","journal-title":"Biochem Pharmacol"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.fpc.0000220561.59972.7a","volume":"16","author":"Hartley D.P.","year":"2006","unstructured":"Hartley DP, Dai X, Yabut J, Chu X, Cheng O, Zhang T, He YD, Roberts C, Ulrich R, Evers R, Evans DC. Pharmacogenet Genomics, Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines.,, 2006, 16,, 579-599,","journal-title":"Pharmacogenet Genomics"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/0091270004269142","volume":"44","author":"Hariparsad N.","year":"2004","unstructured":"Hariparsad N, Nallani SC, Sane RS, Buckley DJ, Buckley AR, Desai PB. J Clin Pharmacol, Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital.,, 2004, 44,, 1273-1281,","journal-title":"J Clin Pharmacol"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/js970372e","volume":"87","author":"Anderle P.","year":"1998","unstructured":"Anderle P, Niederer E, Rubas W, Hilgendorf C, Spahn-Langguth H, Wunderli-Allenspach H, Merkle HP, Langguth P. J Pharm Sci, P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels.,, 1998, 87,, 757-762,","journal-title":"J Pharm Sci"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2133\/dmpk.21.414","volume":"21","author":"Shirasaka Y.","year":"2006","unstructured":"Shirasaka Y, Kawasaki M, Sakane T, Omatsu H, Moriya Y, Nakamura T, Sakaeda T, Okumura K, Langguth P, Yamashita S. Drug Metab Pharmacokinet, Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.,, 2006, 21,, 414-423,","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2133\/dmpk.DMPK-13-SH-068","volume":"29","author":"Chen Q.","year":"2014","unstructured":"Chen Q, Bian Y, Zeng S. Drug Metab Pharmacokinet, Involvement of AP-1 and NF-\u03baB in the up-regulation of P-gp in vinblastine resistant Caco-2 cells.,, 2014, 29,, 223-226,","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref=107","first-page":"1137","volume":"12","author":"Haberl I.","year":"1998","unstructured":"Haberl I, Swatonek H, Schaufler K, Ulsperger E, Wenzl E, Theyer G, Hamilton G, Thalhammer T. Int J Oncol, P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.,, 1998, 12,, 1137-1142,","journal-title":"Int J Oncol"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1016\/S0021-9258(18)53865-5","volume":"268","author":"Herzog C.E.","year":"1993","unstructured":"Herzog CE, Tsokos M, Bates SE, Fojo AT. J Biol Chem, Increased mdr-1\/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists.,, 1993, 268,, 2946-2952,","journal-title":"J Biol Chem"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bjp.0706992","volume":"150","author":"Maier A.","year":"2007","unstructured":"Maier A, Zimmermann C, Beglinger C, Drewe J, Gutmann H. Br J Pharmacol, Effects of budesonide on P-glycoprotein expression in intestinal cell lines.,, 2007, 150,, 361-368,","journal-title":"Br J Pharmacol"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0090-9556(24)15044-1","volume":"27","author":"Lin J.H.","year":"1999","unstructured":"Lin JH, Chiba M, Chen IW, Nishime JA. Drug Metab Dispos, Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450A and p-glycoprotein induction.,, 1999, 27,, 1187-1193,","journal-title":"Drug Metab Dispos"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/jps.20102","volume":"93","author":"Mei Q.","year":"2004","unstructured":"Mei Q, Richards K, Strong-Basalyga K, Fauty SE, Taylor A, Yamazaki M, Prueksaritanont T, Lin JH, Hochman J. J Pharm Sci, Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a\/1b and cytochrome P450 3A1\/2.,, 2004, 93,, 2488-2496,","journal-title":"J Pharm Sci"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0707601","volume":"153","author":"Martin P.","year":"2008","unstructured":"Martin P, Riley R, Back DJ, Owen A. Br J Pharmacol, Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.,, 2008, 153,, 805-819,","journal-title":"Br J Pharmacol"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"236","DOI":"10.18433\/J36016","volume":"14","author":"Abuznait A.H.","year":"2011","unstructured":"Abuznait AH, Patrick SG, Kaddoumi A. J Pharm Pharm Sci, Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties upregulates P-glycoprotein expression and activity.,, 2011, 14,, 236-248,","journal-title":"J Pharm Pharm Sci"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/01480540903130658","volume":"32","author":"Takara K.","year":"2009","unstructured":"Takara K, Hayashi R, Kokufu M, Yamamoto K, Kitada N, Ohnishi N, Yokoyama T. Drug Chem Toxicol, Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein\/MDR1 in Caco-2 cells.,, 2009, 32,, 332-337,","journal-title":"Drug Chem Toxicol"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tox.2014.03.007","volume":"320","author":"Arias A.","year":"2014","unstructured":"Arias A, Rigalli JP, Villanueva SS, Ruiz ML, Luquita MG, Perdomo VG, Vore M, Catania VA, Mottino AD. Toxicology, Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobioticinduced cytotoxicity.,, 2014, 320,, 46-55,","journal-title":"Toxicology"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.106.105668","volume":"318","author":"Ghanem C.I.","year":"2006","unstructured":"Ghanem CI, G\u00f3mez PC, Arana MC, Perassolo M, Carpini GD, Luquita MG, Veggi LM, Catania VA, Bengochea LA, Mottino AD. J Pharmacol Exp Ther, Induction of Rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin.,, 2006, 318,, 1146-1152,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=117","first-page":"203","volume":"66","author":"Sehirli A.O.","year":"2015","unstructured":"Sehirli AO, Cetinel S, Ozkan N, Selman S, Tetik S, Yuksel M, Dulger FGSt. J Physiol Pharmacol, John\u2019s wort may ameliorate 2,4,6-trinitrobenzenesulfonic acid colitis off rats through the induction of pregnane X receptors and\/or P-glycoproteins.,, 2015, 66,, 203-214,","journal-title":"J Physiol Pharmacol"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2011.04.003","volume":"660","author":"Weiss J.","year":"2011","unstructured":"Weiss J, Herzog M, Haefeli WE. Eur J Pharmacol, Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro.,, 2011, 660,, 298-304,","journal-title":"Eur J Pharmacol"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bcp.2012.11.020","volume":"85","author":"Weiss J.","year":"2013","unstructured":"Weiss J, Theile D, Spalwisz A, Burhenne J, Riedel KD, Haefeli WE. Biochem Pharmacol, Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells.,, 2013, 85,, 265-273,","journal-title":"Biochem Pharmacol"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/bbrc.2002.6619","volume":"292","author":"Takara K.","year":"2002","unstructured":"Takara K, Tsujimoto M, Ohnishi N, Yokoyama T. Biochem Biophys Res Commun, Digoxin Up-regulates MDR1 in human colon carcinoma caco-2 cells.,, 2002, 292,, 190-194,","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-291X(03)00922-7","volume":"306","author":"Takara K.","year":"2003","unstructured":"Takara K, Takagi K, Tsujimoto M, Ohnishi N, Yokoyama T. Biochem Biophys Res Commun, Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNA.,, 2003, 306,, 116-120,","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bcp.2004.05.006","volume":"68","author":"Collett A.","year":"2004","unstructured":"Collett A, Tanianis-Hughes J, Warhurst G. Biochem Pharmacol, Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?,, 2004, 68,, 783-790,","journal-title":"Biochem Pharmacol"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0026-895X(25)10521-X","volume":"48","author":"Bhat U.G.","year":"1995","unstructured":"Bhat UG, Winter MA, Pearce HL, Beck WT. Mol Pharmacol, A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.,, 1995, 48,, 682-689,","journal-title":"Mol Pharmacol"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clpt.2004.04.011","volume":"76","author":"Giessmann T.","year":"2004","unstructured":"Giessmann T, May K, Modess C, Wegner D, Hecker U, Zschiesche M, Dazert P, Grube M, Schroeder E, Warzok R, Cascorbi I, Kroemer HK, Siegmund W. Clin Pharmacol Ther, Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.,, 2004, 76,, 192-200,","journal-title":"Clin Pharmacol Ther"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/chir.20400","volume":"19","author":"Shen S.","year":"2007","unstructured":"Shen S, He Y, Zeng S. Chirality, Stereoselective regulation of MDR1 expression in Caco-2 cells by cetirizine enantiomers.,, 2007, 19,, 485-490,","journal-title":"Chirality"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/00912700122010609","volume":"41","author":"St\u00f6rmer E.","year":"2001","unstructured":"St\u00f6rmer E, von Moltke LL, Perloff MD, Greenblatt DJ. J Clin Pharmacol, P-glycoprotein interactions of nefazodone and trazodone in cell culture.,, 2001, 41,, 708-714,","journal-title":"J Clin Pharmacol"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hup.820","volume":"22","author":"Ehret M.J.","year":"2007","unstructured":"Ehret MJ, Levin GM, Narasimhan M, Rathinavelu A. Hum Psychopharmacol, Venlafaxine induces P-glycoprotein in human Caco-2 cells.,, 2007, 22,, 49-53,","journal-title":"Hum Psychopharmacol"},{"key":"ref=128","first-page":"319","volume":"10","author":"Sachs-Barrable K.","year":"2007","unstructured":"Sachs-Barrable K, Thamboo A, Lee SD, Wasan KM. J Pharm Pharm Sci, Lipid excipients Peceol and Gelucire 44\/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.,, 2007, 10,, 319-331,","journal-title":"J Pharm Pharm Sci"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bcp.2010.10.006","volume":"81","author":"Ghanem C.I.","year":"2011","unstructured":"Ghanem CI, Arias A, Novak A, Carpini GD, Villanueva S, Blazquez AG, Marin JJ, Mottino AD, Rubio MC. Biochem Pharmacol, Acetaminophen-induced stimulation of MDR1 expression and activity in rat intestine and in LS 174T human intestinal cell line.,, 2011, 81,, 244-250,","journal-title":"Biochem Pharmacol"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/dmd.30.7.795","volume":"30","author":"Luo G.","year":"2002","unstructured":"Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M, Hamilton G, Rizzo C, Jolley S, Gilbert D, Downey A, Mudra D, Graham R, Carroll K, Xie J, Madan A, Parkinson A, Christ D, Selling B, LeCluyse E, Gan LS. Drug Metab Dispos, CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes.,, 2002, 30,, 795-804,","journal-title":"Drug Metab Dispos"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jps.1133","volume":"90","author":"Perloff M.D.","year":"2001","unstructured":"Perloff MD, Von Moltke LL, Marchand JE, Greenblatt DJ. J Pharm Sci, Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line.,, 2001, 90,, 1829-1837,","journal-title":"J Pharm Sci"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/QAI.0b013e3181f52f0c","volume":"55","author":"Sv\u00e4rd J.","year":"2010","unstructured":"Sv\u00e4rd J, Spiers JP, Mulcahy F, Hennessy M. J Acquir Immune Defic Syndr, Nuclear receptor-mediated induction of CYP450 by antiretrovirals: functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans.,, 2010, 55,, 536-549,","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","volume":"320","author":"Faucette S.R.","year":"2007","unstructured":"Faucette SR, Zhang TC, Moore R, Sueyoshi T, Omiecinski CJ, LeCluyse EL, Negishi M, Wang H. J Pharmacol Exp Ther, Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers.,, 2007, 320,, 72-80,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"30950","DOI":"10.1074\/jbc.271.48.30950","volume":"271","author":"Osborn M.T.","year":"1996","unstructured":"Osborn MT, Chambers TC. J Biol Chem, Role of the stress-activated\/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs.,, 1996, 271,, 30950-30955,","journal-title":"J Biol Chem"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)00045-6","volume":"42","author":"Ford J.M.","year":"1990","unstructured":"Ford JM, Hait WN. Pharmacol Rev, Pharmacology of drugs that alter multidrug resistance in cancer.,, 1990, 42,, 155-199,","journal-title":"Pharmacol Rev"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00685929","volume":"34","author":"Zacherl J.","year":"1994","unstructured":"Zacherl J, Hamilton G, Thalhammer T, Riegler M, Cosentini EP, Ellinger A, Bischof G, Schweitzer M, Teleky B, Koperna T, Wenzl E. Cancer Chemother Pharmacol, Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.,, 1994, 34,, 125-132,","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=137","first-page":"p 25","author":"Song C.W.","year":"1993","unstructured":"Song CW, Lyons JC, Luo Y. Marcel Dekker, New York Basel Hong Kong, Intra- and extracellular pH in solid tumors: influence on therapeutic response. In: Teicher BA (ed) Drug resistance in oncology., , 1993","journal-title":"Marcel Dekker, New York Basel Hong Kong"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1211\/jpp.59.5.0005","volume":"59","author":"Yu L.","year":"2007","unstructured":"Yu L, Zeng S. J Pharm Pharmacol, Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.,, 2007, 59,, 655-660,","journal-title":"J Pharm Pharmacol"},{"key":"ref=139","first-page":"24462","volume":"45","author":"O\u2019Brian C.A.","year":"1985","unstructured":"O\u2019Brian CA, Liskamp RM, Soloman DH, Weinstein IB. Cancer Res, Inhibition of protein kinase C by tamoxifen.,, 1985, 45,, 24462-2465,","journal-title":"Cancer Res"},{"key":"ref=140","first-page":"27","volume":"49","author":"Awad S.","year":"2002","unstructured":"Awad S, Yokozeki H, Miyazaki Y, Igawa K, Minatohara K, Satoh T, Nishioka K. J Med Dent Sci, Glucocorticoids induced the production and gene expression of IL-1alpha through AP-1 and partially NF-kappaB activation in murine epidermal cells.,, 2002, 49,, 27-35,","journal-title":"J Med Dent Sci"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.3748\/wjg.14.7068","volume":"14","author":"Mottino A.D.","year":"2008","unstructured":"Mottino AD, Catania VA. World J Gastroenterol, Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents.,, 2008, 14,, 7068-7074,","journal-title":"World J Gastroenterol"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1515\/BC.2005.060","volume":"386","author":"Burk O.","year":"2005","unstructured":"Burk O, Arnold KA, Geick A, Tegude H, Eichelbaum M. Biol Chem, A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression.,, 2005, 386,, 503-513,","journal-title":"Biol Chem"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"G599","DOI":"10.1152\/ajpgi.00210.2015","volume":"310","author":"Priyamvada S.","year":"2016","unstructured":"Priyamvada S, Anbazhagan AN, Kumar A, Soni V, Alrefai WA, Gill RK, Dudeja PK, Saksena S. Am J Physiol Gastrointest Liver Physiol, Lactobacillus acidophilus stimulates intestinal P-glycoprotein expression via a c-Fos\/c-Jun-dependent mechanism in intestinal epithelial cells.,, 2016, 310,, G599-G560,","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1023\/A:1025096930604","volume":"20","author":"Troutman M.D.","year":"2003","unstructured":"Troutman MD, Trakker DR. Pharm Res, Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.,, 2003, 20,, 1192-1199,","journal-title":"Pharm Res"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jn\/134.1.179","volume":"134","author":"Guo J.Y.","year":"2004","unstructured":"Guo JY, Li X, Browning JD, Rottinghaus GE, Lubahn DB, Constantinou A, Bennink M, MacDonald RS. J Nutr, Dietary soy isoflavones and estrone protect ovariectomized ER alpha KO and wild-type mice from carcinogen-induced colon cancer.,, 2004, 134,, 179-182,","journal-title":"J Nutr"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.1158\/0008-5472.CAN-09-2348","volume":"69","author":"Weige C.C.","year":"2009","unstructured":"Weige CC, Allred KF, Allred CD. Cancer Res, Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon.,, 2009, 69,, 9118-9124,","journal-title":"Cancer Res"},{"key":"ref=147","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.taap.2009.07.026","volume":"240","author":"Riganti C.","year":"2009","unstructured":"Riganti C, Campia I, Polimeni M, Pescarmona G, Ghigo D, Bosia A. Toxicol Appl Pharmacol, Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxiainducible factor-1\u03b1 in human colon cancer cells.,, 2009, 240,, 385-392,","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=148","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/dmd.30.1.96","volume":"30","author":"Ekins S.","year":"2002","unstructured":"Ekins S, Erickson JA. Drug Metab Dispos, A pharmacophore for human pregnane X receptor ligands.,, 2002, 30,, 96-99,","journal-title":"Drug Metab Dispos"},{"key":"ref=149","first-page":"1325","volume":"29","author":"Drocourt L.","year":"2001","unstructured":"Drocourt L, Pascussi JM, Assenat E, Fabre JM, Maurel P, Vilarem MJ. Drug Metab Dispos, Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes.,, 2001, 29,, 1325-1331,","journal-title":"Drug Metab Dispos"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1248\/bpb.b13-00272","volume":"36","author":"Shan Y.Q.","year":"2013","unstructured":"Shan YQ, Zhu YP, Pang J, Wang YX, Song DQ, Kong WJ, Jiang JD. Biol Pharm Bull, Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function.,, 2013, 36,, 1562-1569,","journal-title":"Biol Pharm Bull"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/0006-2952(94)90580-0","volume":"48","author":"Wils P.","year":"1994","unstructured":"Wils P, Phung-Ba V, Warnery A, Lechardeur D, Raeissi S, Hidalgo IJ, Scherman D. Biochem Pharmacol, Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.,, 1994, 48,, 1528-1530,","journal-title":"Biochem Pharmacol"},{"key":"ref=152","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0922-4106(95)90193-0","volume":"288","author":"Phung-Ba V.","year":"1995","unstructured":"Phung-Ba V, Warnery A, Scherman D, Wils P. Eur J Pharmacol, Interaction of pristinamycin IA with P-glycoprotein in human intestinal epithelial cells.,, 1995, 288,, 187-192,","journal-title":"Eur J Pharmacol"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.HYP.0000097547.35570.70","volume":"42","author":"Kobayashi N.","year":"2003","unstructured":"Kobayashi N, Mita S, Yoshida K, Honda T, Kobayashi T, Hara K, Nakano S, Tsubokou Y, Matsuoka H. Hypertension, Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 Via NF-kappaB induced by oxidative stress.,, 2003, 42,, 1004-1013,","journal-title":"Hypertension"},{"key":"ref=154","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1046\/j.1471-4159.2003.02061.x","volume":"87","author":"Nwaozuzu O.M.","year":"2003","unstructured":"Nwaozuzu OM, Sellers LA, Barrand MA. J Neurochem, Signalling pathways influencing basal and H2O2-induced P-glycoprotein expression in endothelial cells derived from the blood-brain barrier.,, 2003, 87,, 1043-1051,","journal-title":"J Neurochem"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/jpet.105.098160","volume":"317","author":"Faucette S.R.","year":"2006","unstructured":"Faucette SR, Sueyoshi T, Smith CM, Negishi M, LeCluyse EL, Wang H. J Pharmacol Exp Ther, Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor.,, 2006, 317,, 1200-1209,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=156","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1074\/jbc.M001215200","volume":"275","author":"Moore L.B.","year":"2000","unstructured":"Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA. J Biol Chem, Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.,, 2000, 275,, 15122-15127,","journal-title":"J Biol Chem"},{"key":"ref=157","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/156720208784310196","volume":"5","author":"Lombardo L.","year":"2008","unstructured":"Lombardo L, Pellitteri R, Balazy M, Cardile V. Curr Neurovasc Res, Induction of nuclear receptors and drug resistance in the brain microvascular endothelial cells treated with antiepileptic drugs.,, 2008, 5,, 82-92,","journal-title":"Curr Neurovasc Res"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(94)90029-9","volume":"643","author":"Lukasiuk K.","year":"1994","unstructured":"Lukasiuk K, Kaczmarek L. Brain Res, AP-1 and CRE DNA binding activities in rat brain following pentylenetetrazole induced seizures.,, 1994, 643,, 227-233,","journal-title":"Brain Res"},{"key":"ref=159","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0016-5085(76)80353-8","volume":"71","author":"Wald A.","year":"1976","unstructured":"Wald A, Back C, Bayless TM. Gastroenterology, Effect of caffeine on the human small intestine.,, 1976, 71,, 738-742,","journal-title":"Gastroenterology"},{"key":"ref=160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2006.01.020","volume":"313","author":"Shen Q.","year":"2006","unstructured":"Shen Q, Lin Y, Handa T, Doi M, Sugie M, Wakayama K, Okada N, Fujita T, Yamamoto A. Int J Pharm, Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.,, 2006, 313,, 49-56,","journal-title":"Int J Pharm"},{"key":"ref=161","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.10175","volume":"91","author":"Hugger E.D.","year":"2002","unstructured":"Hugger ED, Audus KL, Borchardt RT. J Pharm Sci, Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.,, 2002, 91,, 1980-1990,","journal-title":"J Pharm Sci"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1211\/jpp.60.12.0009","volume":"60","author":"Shen Q.","year":"2008","unstructured":"Shen Q, Li W, Lin Y, Katsumi H, Okada N, Sakane T, Fujita T, Yamamoto A. J Pharm Pharmacol, Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.,, 2008, 60,, 1633-1641,","journal-title":"J Pharm Pharmacol"},{"key":"ref=163","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2217\/nnm.10.53","volume":"5","author":"Alvarez-Lorenzo C.","year":"2010","unstructured":"Alvarez-Lorenzo C, Rey-Rico A, Brea J, Loza MI, Concheiro A, Sosnik A. Nanomedicine (Lond), Inhibition of P-glycoprotein pumps by PEO-PPO amphiphiles: branched versus linear derivatives.,, 2010, 5,, 1371-1383,","journal-title":"Nanomedicine (Lond)"},{"key":"ref=164","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1208\/ps040440","volume":"4","author":"Johnson B.M.","year":"2002","unstructured":"Johnson BM, Charman WN, Porter CJH. AAPS PharmSci, An in vitro examination of the impact of polyehtylene glycol 400, pluronic P 85 and vitamin E D-a-tocopheryl polyethylene glycol 1000 succinate on p-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.,, 2002, 4,, E40-,","journal-title":"AAPS PharmSci"},{"key":"ref=165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejpb.2007.03.022","volume":"66","author":"Chiappetta D.A.","year":"2007","unstructured":"Chiappetta DA, Sosnik A. Eur J Pharm Biopharm, Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.,, 2007, 66,, 303-317,","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=166","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2174\/138945011795906615","volume":"12","author":"Alvarez-Lorenzo C.","year":"2011","unstructured":"Alvarez-Lorenzo C, Sosnik A, Concheiro A. Curr Drug Targets, PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy.,, 2011, 12,, 1112-1130,","journal-title":"Curr Drug Targets"},{"key":"ref=167","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","volume":"54","author":"Kabanov A.V.","year":"2002","unstructured":"Kabanov AV, Batrakova EV, Alakhov VY. Adv Drug Deliv Rev, Pluronic\u00ae block copolymers for overcoming drug resistance in cancer.,, 2002, 54,, 759-779,","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=168","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1124\/dmd.105.005256","volume":"33","author":"Wolf K.K.","year":"2005","unstructured":"Wolf KK, Wood SG, Hunt JA, Walton-Strong BW, Yasuda K, Lan L, Duan SX, Hao Q, Wrighton SA, Jeffery EH, Evans RM, Szakacs JG, von Moltke LL, Greenblatt DJ, Court MH. Drug Metab Dispos, Schuetz, E.G.; Sinclair, P.R.; Sinclair, J.F. Role of the nuclear receptor pregnane X receptor in acetaminophen hepatotoxicity.,, 2005, 33,, 1827-1836,","journal-title":"Drug Metab Dispos"},{"key":"ref=169","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1124\/mol.113.086298","volume":"84","author":"Slosky L.M.","year":"2013","unstructured":"Slosky LM, Thompson BJ, Sanchez-Covarrubias L, Zhang Y, Laracuente ML, Vanderah TW, Ronaldson PT, Davis TP. Mol Pharmacol, Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism.,, 2013, 84,, 774-786,","journal-title":"Mol Pharmacol"},{"key":"ref=170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0022-3565(24)39291-2","volume":"293","author":"Mottino A.D.","year":"2000","unstructured":"Mottino AD, Hoffman T, Jennes L, Vore M. J Pharmacol Exp Ther, Expression and localization of multidrug resistant protein MRP2 in rat small intestine.,, 2000, 293,, 717-723,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=171","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0002-9440(10)64794-3","volume":"157","author":"Fromm M.F.","year":"2000","unstructured":"Fromm MF, Kauffmann HM, Fritz P, Burk O, Kroemer HK, Warzok RW, Eichelbaum M, Siegmund W, Schrenk D. Am J Pathol, The effect of rifampin treatment on intestinal expression of human MRP transporters.,, 2000, 157,, 1575-1580,","journal-title":"Am J Pathol"},{"key":"ref=172","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clpt.2005.11.004","volume":"79","author":"Oswald S.","year":"2006","unstructured":"Oswald S, Haenisch S, Fricke C, Sudhop T, Remmler C, Giessmann T, Jedlitschky G, Adam U, Dazert E, Warzok R, Wacke W, Cascorbi I, Kroemer HK, Weitschies W, Von Bergmann K, Siegmund W. Clin Pharmacol Ther, Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in.,, 2006, 79,, 206-217,","journal-title":"Clin Pharmacol Ther"},{"key":"ref=173","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/jac\/dkq324","volume":"65","author":"K\u00f6nig S.K.","year":"2010","unstructured":"K\u00f6nig SK, Herzog M, Theile D, Zembruski N, Haefeli WE, Weiss J. J Antimicrob Chemother, Impact of drug transporters on cellular resistance towards saquinavir and darunavir.,, 2010, 65,, 2319-2328,","journal-title":"J Antimicrob Chemother"},{"key":"ref=174","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.bcp.2009.07.006","volume":"78","author":"Theile D.","year":"2009","unstructured":"Theile D, Grebhardt S, Haefeli WE, Weiss J. Biochem Pharmacol, Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy.,, 2009, 78,, 1366-1373,","journal-title":"Biochem Pharmacol"},{"key":"ref=175","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1248\/bpb.34.1418","volume":"34","author":"Shibayama Y.","year":"2011","unstructured":"Shibayama Y, Iwashita Y, Yoshikawa Y, Kondo T, Ikeda R, Takeda Y, Osada T, Sugawara M, Yamada K, Iseki K. Biol Pharm Bull, Effect of 5-fluorouracil treatment on SN-38 absorption from intestine in rats.,, 2011, 34,, 1418-1425,","journal-title":"Biol Pharm Bull"},{"key":"ref=176","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cbi.2010.12.026","volume":"191","author":"Ebert B.","year":"2011","unstructured":"Ebert B, Kisiela M, Ws\u00f3l V, Maser E. Chem Biol Interact, Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.,, 2011, 191,, 239-249,","journal-title":"Chem Biol Interact"},{"key":"ref=177","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/mp300178a","volume":"9","author":"Herraez E.","year":"2012","unstructured":"Herraez E, Gonzalez-Sanchez E, Vaquero J, Romero MR, Serrano MA, Marin JJG, Briz O. Mol Pharm, Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.,, 2012, 9,, 2565-2576,","journal-title":"Mol Pharm"},{"key":"ref=178","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/jphp.12455","volume":"67","author":"Theile D.","year":"2015","unstructured":"Theile D, Allendorf D, K\u00f6hler B, Jassowicz A, Weiss J. J Pharm Pharmacol, Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell lines.,, 2015, 67,, 1575-1584,","journal-title":"J Pharm Pharmacol"},{"key":"ref=179","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.bcp.2006.03.009","volume":"71","author":"Huang R.","year":"2006","unstructured":"Huang R, Murry DJ, Kolwankar D, Hall SD, Foster DR. Biochem Pharmacol, Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines.,, 2006, 71,, 1695-1704,","journal-title":"Biochem Pharmacol"},{"key":"ref=180","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.108.025643","volume":"37","author":"Arias A.","year":"2009","unstructured":"Arias A, Villanueva SSM, Ruiz ML, Luquita MG, Veggi LM, Pellegrino M, Vore M, Catania VA, Mottino AD. Drug Metab Dispos, Regulation of expression and activity of rat intestinal multidrug resistance-associated protein 2 by cholestatic estrogens.,, 2009, 37,, 1277-1285,","journal-title":"Drug Metab Dispos"},{"key":"ref=181","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/mol.105.013144","volume":"68","author":"Jones B.R.","year":"2005","unstructured":"Jones BR, Li W, Cao J, Hoffman TA, Gerk PM, Vore M. Mol Pharmacol, The role of protein synthesis and degradation in the post-transcriptional regulation of rat multidrug resistance-associated protein 2 (Mrp2, Abcc2).,, 2005, 68,, 701-710,","journal-title":"Mol Pharmacol"},{"key":"ref=182","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2009.09.014","volume":"623","author":"Ruiz M.L.","year":"2009","unstructured":"Ruiz ML, Villanueva SSM, Luquita MG, Pellegrino JM, Rigalli JP, Arias A, S\u00e1nchez Pozzi EJ, Mottino AD, Catania VA. Eur J Pharmacol, Induction of intestinal multidrug resistance-associated protein 2 (Mrp2) by spironolactone in rats.,, 2009, 623,, 103-106,","journal-title":"Eur J Pharmacol"},{"key":"ref=183","doi-asserted-by":"crossref","first-page":"45","DOI":"10.18433\/J33S3Z","volume":"11","author":"Jia J.X.","year":"2008","unstructured":"Jia JX, Wasan KM. J Pharm Pharm Sci, Effects of monoglycerides on rhodamine 123 accumulation, estradiol 17 beta-D-glucuronide bidirectional transport and MRP2 protein expression within Caco-2 cells.,, 2008, 11,, 45-62,","journal-title":"J Pharm Pharm Sci"},{"key":"ref=184","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bcp.2013.04.002","volume":"85","author":"Sharma D.","year":"2013","unstructured":"Sharma D, Lau AJ, Sherman M, Chang TKH. Biochem Pharmacol, Agonism of human pregnane X receptor by rilpivirine and etravirine: comparison with first generation nonnucleoside reverse transcriptase inhibitors.,, 2013, 85,, 1700-1711,","journal-title":"Biochem Pharmacol"},{"key":"ref=185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijantimicag.2013.10.003","volume":"43","author":"Weiss J.","year":"2014","unstructured":"Weiss J, Becker JP, Haefeli WE. Int J Antimicrob Agents, Telaprevir is a substrate andmoderate inhibitor of P-glycoprotein, a strong inductor of ABCG2, but not an activator of PXR in vitro.,, 2014, 43,, 184-188,","journal-title":"Int J Antimicrob Agents"},{"key":"ref=186","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/jac\/dkq501","volume":"66","author":"Zembruski N.C.L.","year":"2011","unstructured":"Zembruski NCL, B\u00fcchel G, J\u00f6dicke L, Herzog M, Haefeli WE, Weiss J. J Antimicrob Chemother, Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro.,, 2011, 66,, 802-812,","journal-title":"J Antimicrob Chemother"},{"key":"ref=187","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1128\/AAC.01527-10","volume":"55","author":"Zembruski N.C.L.","year":"2011","unstructured":"Zembruski NCL, Haefeli WE, Weiss J. Antimicrob Agents Chemother, Interaction potential of etravirine with drug transporters assessed in vitro.,, 2011, 55,, 1282-1284,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=188","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/me.2004-0434","volume":"19","author":"Masuyama H.","year":"2005","unstructured":"Masuyama H, Suwaki N, Tateishi Y, Nakatsukasa H, Segawa T, Hiramatsu Y. Mol Endocrinol, The pregnane X receptor regulates gene expression in a ligand- and promoterselective fashion.,, 2005, 19,, 1170-1180,","journal-title":"Mol Endocrinol"},{"key":"ref=189","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bcp.2015.01.013","volume":"94","author":"Ghanem C.I.","year":"2015","unstructured":"Ghanem CI, Rudraiah S, Bataille AM, Vigo MB, Goedken MJ, Manautou JE. Biochem Pharmacol, Role of nuclear factor-erythroid 2-related factor 2 (Nrf2) in the transcriptional regulation of brain ABC transporters during acute acetaminophen (APAP) intoxication in mice.,, 2015, 94,, 203-211,","journal-title":"Biochem Pharmacol"},{"key":"ref=190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.110.170084","volume":"335","author":"Aleksunes L.M.","year":"2010","unstructured":"Aleksunes LM, Goedken MJ, Rockwell CE, Thomale J, Manautou JE, Klaassen CD. J Pharmacol Exp Ther, Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.,, 2010, 335,, 2-12,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=191","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/hep.21831","volume":"46","author":"Maher J.M.","year":"2007","unstructured":"Maher JM, Dieter MZ, Aleksunes LM, Slitt AL, Guo G, Tanaka Y, Scheffer GL, Chan JY, Manautou JE, Chen Y, Dalton TP, Yamamoto M, Klaassen CD. Hepatology, Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway.,, 2007, 46,, 1597-1610,","journal-title":"Hepatology"},{"key":"ref=192","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/carcin\/bgt067","volume":"34","author":"Edvardsson K.","year":"2013","unstructured":"Edvardsson K, Nguyen-Vu T, Kalasekar SM, Ponten F, Gustafsson JA, Williams C. Carcinogenesis, Estrogen receptor beta expression induces changes in the microRNA pool in human colon cancer cells.,, 2013, 34,, 1431-1441,","journal-title":"Carcinogenesis"},{"key":"ref=193","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pupt.2014.12.001","volume":"30","author":"Weiss J.","year":"2015","unstructured":"Weiss J, Baumann S, Theile D, Haefeli WE. Pulm Pharmacol Ther, Desmethyl bosentan displays a similar in vitro interaction profile as bosentan.,, 2015, 30,, 80-86,","journal-title":"Pulm Pharmacol Ther"},{"key":"ref=194","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00280-011-1715-8","volume":"68","author":"Weiss J.","year":"2011","unstructured":"Weiss J, Haefeli WE. Cancer Chemother Pharmacol, Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro.,, 2011, 68,, 1093-1098,","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=195","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2013.01.010","volume":"701","author":"Weiss J.","year":"2013","unstructured":"Weiss J, Theile D, R\u00fcppell MA, Speck T, Spalwisz A, Haefeli WE. Eur J Pharmacol, Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro.,, 2013, 701,, 168-175,","journal-title":"Eur J Pharmacol"},{"key":"ref=196","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/bph.12126","volume":"169","author":"Fahrmayr C.","year":"2013","unstructured":"Fahrmayr C, K\u00f6nig J, Auge D, Mieth M, M\u00fcnch K, Segrestaa J, Pfeifer T, Treiber A, Fromm MF. Br J Pharmacol, Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line.,, 2013, 169,, 21-33,","journal-title":"Br J Pharmacol"},{"key":"ref=197","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","volume":"6","author":"Porter C.J.","year":"2007","unstructured":"Porter CJ, Trevaskis NL, Charman WN. Nat Rev Drug Discov, Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.,, 2007, 6,, 231-248,","journal-title":"Nat Rev Drug Discov"},{"key":"ref=198","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-3565(24)35309-1","volume":"292","author":"Gotoh Y.","year":"2000","unstructured":"Gotoh Y, Suzuki H, Kinoshita S, Hirohashi T, Kato Y, Sugiyama Y. J Pharmacol Exp Ther, Involvement of an organic anion transporter (canalicular multispecific organic anion transporter\/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathioneconjugates in rats.,, 2000, 292,, 433-439,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=199","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)29314-9","volume":"299","author":"Taipalensuu J.","year":"2001","unstructured":"Taipalensuu J, T\u00f6rnblom H, Lindberg G, Einarsson C, Sj\u00f6qvist F, Melhus H, Garberg P, Sj\u00f6str\u00f6m B, Lundgren B, Artursson P. J Pharmacol Exp Ther, Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.,, 2001, 299,, 164-170,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=200","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bcp.2011.07.081","volume":"82","author":"Peroni R.N.","year":"2011","unstructured":"Peroni RN, Di Gennaro SS, Hocht C, Chiappetta DA, Rubio MC, Sosnik A, Bramuglia GF. Biochem Pharmacol, Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2\/BCRP in the gastrointestinal tract of the rat.,, 2011, 82,, 1227-1233,","journal-title":"Biochem Pharmacol"},{"key":"ref=201","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3382\/ps\/pew148","volume":"95","author":"Gou M.","year":"2016","unstructured":"Gou M, Dai X, Hu D, Zhang Y, Sun Y, Ren W, Wang L. Poult Sci, Potential pharmacokinetic effect of rifampicin on enrofloxacin in broilers: Roles of P-glycoprotein and BCRP induction by rifampicin.,, 2016, 95,, 2129-2135,","journal-title":"Poult Sci"},{"key":"ref=202","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2011.10.004","volume":"672","author":"Wright J.A.","year":"2011","unstructured":"Wright JA, Haslam IS, Coleman T, Simmons NL. Eur J Pharmacol, Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers.,, 2011, 672,, 70-76,","journal-title":"Eur J Pharmacol"},{"key":"ref=203","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4161\/cbt.4.7.1826","volume":"4","author":"Burger H.","year":"2005","unstructured":"Burger H, Van Tol H, Brok M, Wiemer EA, De Brujin EA, Guetens G, De Boeck G, Sparreboom A, Verweij J, Nooter K. Cancer Biol Ther, Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps.,, 2005, 4,, 747-752,","journal-title":"Cancer Biol Ther"},{"key":"ref=204","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1002\/jps.23680","volume":"102","author":"Bachmeier C.","year":"2013","unstructured":"Bachmeier C, Levin GM, Beaulieu-Abdelahad D, Reed J, Mullan M. J Pharm Sci, Effect of venlafaxine and desvenlafaxine on drug efflux protein expression and biodistribution in vivo.,, 2013, 102,, 3838-3843,","journal-title":"J Pharm Sci"},{"key":"ref=205","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/carcin\/bgi139","volume":"26","author":"Ebert B.","year":"2005","unstructured":"Ebert B, Seidel A, Lampen A. Carcinogenesis, Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists.,, 2005, 26,, 1754-1763,","journal-title":"Carcinogenesis"},{"key":"ref=206","doi-asserted-by":"crossref","first-page":"23812","DOI":"10.1074\/jbc.M604890200","volume":"281","author":"Szatmari I.","year":"2006","unstructured":"Szatmari I, V\u00e1mosi G, Brazda P, Balint BL, Benko S, Sz\u00e9les L, Jeney V, Ozvegy-Laczka C, Sz\u00e1nt\u00f3 A, Barta E, Balla J, Sarkadi B, Nagy L. J Biol Chem, Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells.,, 2006, 281,, 23812-23823,","journal-title":"J Biol Chem"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"e21880","DOI":"10.1002\/jbt.21880","volume":"31","author":"Lin Y.","year":"2017","unstructured":"Lin Y, Bircsak KM, Gorczyca L, Wen X, Aleksunes LM. J Biochem Mol Toxicol, Regulation of the placental BCRP transporter by PPAR gamma.,, 2017, 31,, e21880-,10.1002\/jbt.21880","journal-title":"J Biochem Mol Toxicol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/160748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T01:04:41Z","timestamp":1751504681000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/160748\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":207,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,5,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180327092639","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-08-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}